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Pontages infra-inguinaux dans les artériopathies occlusives périphériques : Quand les bras 
viennent au secours des jambes. 
Les progrès de la médecine ont permis d'améliorer aussi bien la qualité que l'espérance de vie. A ce 
jour, ceux-ci n'ont malheureusement pas révolutionné la chirurgie vasculaire périphérique. En effet, 
malgré l'apport de la bio-ingénieurie, les veines restent plus performantes en termes de longévité 
que les conduits synthétiques dans les interventions de revascularisation réalisées dans le contexte 
d'une ischémie chronique. Malheureusement, le nombre de veines couramment utilisées et reconnu 
comme premier choix (veine saphène) et limité. 
L'étude rétrospective réalisée avait pour but de démontrer que les veines des membres supérieurs 
constituaient plus qu'un dernier choix, plutôt une alternative chez des patients qui ne disposaient 
plus de veines saphènes ou si celles-ci étaient de mauvaise qualité. 
Nous avons donc revu une série consécutive de patients ayant bénéficié de pontage avec des veines 
de bras (céphalique, basilique ou mixte) entre 2001 et 2006. L'âge, les commorbidités, les 
symptômes, ainsi que les rapports angiologiques de ces patients ont également été analysés. 
Pendant ces 5 années, 62 pontages chez 56 patients (6 patients opérés des 2 côtés) utilisant des 
veines de bras ont été réalisés dans notre service de chirurgie thoracique et vasculaire au CHUV. 
L'analyse des résultats a permis de démontrer que le taux de perméabilité à 3 ans est tout à fait 
satisfaisant pour les pontages réalisés avec des veines de bras et même comparable à celui obtenu 
avec les veines saphènes. De plus, nous avons mis en évidence l'importance de la qualité de la veine 
choisie, l'influence de son diamètre (une augmentation du diamètre de la veine permet une 
meilleure survie du pontage). 
En conclusion, les veines de bras sont plus qu'un dernier choix dans la revascularisation des membres 
inférieurs. On devrait prendre en considération leur utilisation à chaque fois qu'elles sont de bonne 
qualité et d'un diamètre correcte chez les patients qui ne disposent plus de veine saphène, ou même 
si celles-ci sont présentes, mais de mauvaise qualité. Ceci augmente le nombre de segments veineux 
à disposition, ce qui permettra d'utiliser encore moins souvent les conduits synthétiques. 
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Objectives: Determine if arm veins are good conduits for infrainguinal revascularisation and should be 
used when good quality saphenous vein is not available. 
Design: Retrospective study. 
Available online 3 September 2011 
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Materia/s and met/wds: We evaluated a consecutive series of infrainguinal bypass (IB) using arm vein 
conduits from March 2001 to December 2006.We selected arm vein by preoperative ultrasound mapping 
to identify suitable veins. We measured vein diameter and assessed vein wall quality. We followed 
patients with systematic duplex imaging at 1 week, 1, 3, 6 and 12 months, and annually thereafter. We 
treated significative stenoses found during the follow-up. 
lnfrainguinal revascularisation 
Arm vein 
Resu/ts: We performed 56 infrainguinal revascularisation using arm vein conduits in 56 patients. Primary 
patency rates at 1, 2 and 3 years were 65%, 51 % and 47%. Primary assisted patencies at 1, 2 and 3 years 
were 96%, 96% and 82%. Secondary patency rates at 1, 2 and 3 years were 92%, 88% and 88%. The three-
year limb salvage rate was 88%. 
Co11c/11sio11s: We conclude that infrainguinal bypass using arm vein for conduits gives good patency rates, 
if selected by a preoperative US mapping to use the best autogenous conduit available. 
© 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. Ali rights reserved. 
With the improvement in the quality of life and medical ther-
apies, there is an increase in both life expectancy and the patient's 
expectations. Medicine has to cape with older patients and their 
growing Jists of comorbidities, 1 ther{'l,{Y complicating the frame-
work conditions for vascular surgery .. """ 
In fact, the ageing patient is apt to benefit from a bypass (be it 
cardiac or Jeg), and surgical options are now considered even for 
elderly patients. Nevertheless, the fundamental problem of 
a limited number of great saphenous veins (GSVs) available per 
patient still remains. 
Bioengineering has aire ad y tried to solve this Jack of conduit, but 
Without success.2 Veins are still considered superior to prostheses 
in terms oflong-term patency,3- 14 and the GSV remains the conduit 
of choice.6- 12 However, other surgeons or pathologies may have 
laid claim first to this valued vein. 
œ To access continuing medical education questions on this paper, please go 
to www.vasculareducation.com and click on 'CME' 
' Corresponding author. Tel.: +41 76 563 37 33. 
E-mail address: Frederic.Vauclair@clrnv.ch (F. Vauclair). 
Based on numerous studies,3•6•15 vascular surgery teams still 
advocate an all-autogenous policy for infrainguinal bypass (IB). 
What remains unclear is which vein should be used. 
We decided to work in the 'do the best operation first' fashion 
and this series reflects consecutive IB where the arm vein was the 
best alternative conduit for lower extremity revascularisations 
based on systematic preoperative duplex mapping. 
The aim of this study was to evaluate the arm veins as conduits 
for IB and to look for factors that could influence the survival and 
the patency rates. 
Matel'ials and Methods 
Between March 2001 and December 2006, ail patients under-
going infrainguinal arterial revascularisation at the Lausanne 
University Hospital (Centre Hospitalier Universitaire Vaudois-
CHUV) were recorded prospectively in a computerised database. 
Retrospectively, we selected a consecutive series of IB where the 
arm vein served as graft. Operative reports were then coordinated 
with patients' demographics, comorbidities, presenting symptoms 
and angiographie reports. Staging of arteriopathy was done using 
1078-5884/$ - see front matter © 2011 European Society for Vascular Surge1y. Published by Elsevier Ltd. Ali rights reserved. 
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Rutherford categories. Patients were stratified using ASA anaes-
thesiologic scoring. 16·17 
During this 5-year period, 62 lower extremity revascularisa-
tions using arm vein conduits were performed in 56 patients 
(six patients were operated on both legs). This represents 
approximately 7% of ail IBs done during this period at our 
department. To simplify demographic and statistical analysis, we 
choose to exclude the second operation performed on six 
patients. 
Ali patients underwent preoperative clinical examination, 
angiography or angio-CT, as well as both arterial and venous 
ultrasound (US) scanning. When lower limbs did not provide 
enough venous material to perform the planned bypass, upper 
limbs were likewise examined. After inspection and palpation 
with and without application of a tourniquet, deep veins were 
scanned using B-mode sonography to rule out a deep vein 
thrombosis. Then the superficial veins, the great and short 
saphenous veins or the cephalic and basilic veins, as well as 
their main branches, were located and scanned throughout their 
courses, also using B-mode. Diameters were assessed at several 
levels, and alterations, such as thrombosis, aneurysm, focal wall 
thickening or calcifications and intraluminal webs were sought. 
'Any patent venous segment showing a straight course, an even 
and thin wall and a minimal luminal diameter of 2.5 mm was 
regarded as suitable for use as a conduit' (we defined vein of 
poor quality when one or more criteria were observed, such as 
diameter <2.5 mm, thrombosis, aneurysm, focal wall thickening 
or calcifications and intraluminal webs). When the diameter was 
less than 2.5 mm, measurements were repeated after heating 
the limb and asking the patient to perform movements with his 
foot or hand while wearing a cuff inflated to 80 mmHg 
Figure 1. Pre-operative duplex mapping. 
proximally on the limb. Ali ultrasound studies were performed 
using linear 5-12 MHz transducers (Envisor and HD! 5000, 
Philips Medical Systems Switzerland, Gland, Switzerland; 
Vingmed System V, GE Medical Systems Switzerland, Glattbrugg, 
Switzerland). 
Then, based on preoperative US mapping findings (Fig. 1 ), 
selected veins were isolated and harvested after ligation of the 
collaterals (Fig. 2). When a single segment of suitable length was 
not present, we performed spliced vein bypasses (composite) using 
venous-to-venous and end-to-end anastomosis done with single 
stitches (polypropylene 7.0). 
Before arterial flow interruption and arteriotomy, we used 
a single dose (50 UI/Kg) of intravenous heparin. 
At the end of the procedure, the flow was measured using 
a transit time principle probe (Medistim, Oslo, Norway) placed 
around the venous conduitjust distal to the proximal anastomosis. 
When blood flow was under 25 ml/min, an intraoperative digital 
subtraction angiography (OSA) was performed in order to detect 
and correct any stenosis or other bypass problem. If nothing was 
found, we assumed that low flow was due to poor run-off. 
In order to reduce operative time, the operation was performed 
using a two-team approach. 
For below-the-knee bypasses, anticoagulation therapy with 
intravenous heparin was started 6 h post-op and then the patient 
was later switched to an oral anticoagulant on day seven (to 
minimise haemorrhagic complications and to delay oral 
Figure 2. Preparation of arm vein with ligation of collaterals. 
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anticoagulation if any bypass abnormality was found on day seven 
duplex imaging). 
After surgery, patients underwent periodic systematic evalu-
ations at 1 week, 1, 3, 6 and 12 months, and annually thereafter. 
·The se included history and lower limb inspection looking for 
progression of ischaemic symptoms. We performed ankle and toe 
pressure measurements, and duplex imaging of the entire length 
of the bypass, as well as of the feeding artery and the main 
outflow vesse!. Variations in the diameter, thrombus and location 
of the anastomoses were assessed by B-mode and stenoses were 
sought using colour Doppler. Spectral Doppler with an angle of 
60° was used to assess velocity waves and peak systolic velocities 
(PSVs) proximal to, at and distal to sites of stenosis. Velocity 
ratios were recorded across ail lesions and were calculated by 
dividing the maximal PSV at the stenosis site by the PSV proximal 
to the stenosis. The severity of a stenosis was considered to be 
about 50% when the PSV ratio was 2.2-2.5, and at least 70% when 
the systolic wave was dampened distal to the stenosis and the 
PSV ratio was 3.5 or more. Then ail stenoses were carefully 
scanned using B-mode to assess their minimal luminal diameter, 
length and cause (valve, thrombus, conduit stricture, dissection or 
plaque). Stenoses of 50% were monitored closely, whereas 
stenoses of 70% or more were treated using either common 
percutaneous balloon angioplasty or surgically with a venous 
patch.20-23 
De.finitions 
Ail terms used to report patencies and bypass characteristics are 
based on Rutherford's24 recommendations. 
Statistical ana/ysis 
Statistical analysis was performed using SAS v.9.2 (SAS Inc, Ca1y, 
NC, USA). Results were expressed as the number of subjects and 
(percentage) or as the mean ±standard deviation, unless otherwise 
stated. Patency rates were assessed by the life table method using 
2-month intervals and the results were expressed as 1, 2 or 3-year 
patency rates and [95% confidence interval]. Factors significantly 
related to patency rates were assessed using the log-Rank test. 
Statistical significance was set at p < 0.05. 
Results 
Data from 56 patients aged 75.7 ± 10.5 years ((mean ± SD) 
range: 48-93 years) were collected. The male/female ratio was 1/1 
(28 M/28 F). The main clinical characteristics of the patients at 
baseline are summarised in Table 1. Staging of arteriopathy shows 
that two-thirds of the procedures were performed for Rutherford 
categories 5 or 6 (Table 1 ). 
The GSV was missing in 53.6% (30/56), present but tao short or 
of poor quality in 46.4% (26/56). Table 2 shows the principal bypass 
characteristics. Here, it is important to mention that the rate of recto 
operations reached 48% and that infrapopliteal bypasses, at 50%, 
were the most commonly performed. 
Six patients have been operated on bath legs. Data from the 
second contralateral intervention were excluded from the analysis 
and are reported separately. 
Survival and complication rates 
There was no in-hospital death. Local complications were 
observed in four patients (7.1%), corresponding to three haemato-
mas in the arm (requiring evacuation) and one transient paraes-
thesia of the fourth and fifth digits after cephalic harvesting. 
Table 1 
Patients' characteristics at the time of bypass and staging of Arteriopathy.24 
Category O: asymptomatic; 1: mild claudication; 2: moderate claudication; 3: 
severe claudication; 4: ischaemic rest pain; 5: minor tissue loss-nonhealing 
ulcer, focal gangrene with diffuse pedal ischaemia; 6: major tissue loss-
extending above transmetatarsal level, functional foot no longer salvageable. 
Results are expressed as number of subjects and (percentage). 
Male sex 
Age (years) 
Hypertension 
Hypercholesterolaemia 
Diabetes rnellitus 
Current srnoker 
Rena! insufficiency 
Glomerular filtration rate (ml/min) 
Coronary disease 
Rutherford's category 
3 
4 
5 
6 
28 {50.0) 
75.7 ± 10.6 
47 (83.9) 
21 (37.5) 
21 (37.5) 
30 (53.6) 
31 {55.4) 
37.1 ± 12.7 
37 (66.1) 
6 (10.7) 
12 (21.4) 
23 (41.1) 
15 (26.8) 
Survival rates were 85%, 72% and 50% at 12, 24 and 36 months, 
respectively. 
Patency and limb salvage 
Primary patency rates at 1, 2 and 3 years were 65 ± 6.7%, 
51 ± 7.3% and 47 ± 7.6%. Primary assisted patency rates at 1, 2 and 3 
years were 96 ± 3.0%, 96 ± 3.0% and 82 ± 6.9%. Secondary patency 
rates at 1, 2 and 3 years were 92 ± 3.7%, 88 ± 4.7% and 88 ± 4.7% 
(Fig. 3). 
Table 2 
Bypass characteristics. Results are expressed as number of bypass procedures and 
(percentage) or as rnean ± standard deviation. *Distal anastornosis is beneath the 
trifurcation ( corresponding to anterior/posterior tibial or peroneal artery or pedal 
arch). 
Vein diameter (mm) 
Venous conduit characteristics 
Single vesse! (cephalic, basilic or brachial) 
Spliced arrn-leg (saphenous and arrn veins) 
Spliced arrn-arm (basilic and cephalic) 
Type of revascularization 
Above-knee bypass 
Below-knee bypass 
Distal bypass* 
Elective surgery 
Redo surge1y 
Take-off vesse! 
Cornrnon fernoral artery (CFA) 
Superficial fernoral arte1y 
Profound fernoral artery {PFA) 
Suprageniculate popliteal artery (SPA) 
lnfrageniculate pop!iteal artery 
Aortic-PFA bypass 
SFA-ATA bypass {proximal part) 
CFA-SPA bypass 
Landing vessds 
Suprageniculate pop!iteal artery 
Geniculate popliteal artery {GPA) 
lnfrageniculate popliteal artery 
Peroneal artery (PA) 
Anterior tibial artery 
Posterior tibial artery 
Dorsalis pedis artery (DPA) 
SFA-PA bypass 
GPA-DPA bypass 
4.1±1.1 
413-5]; (2-8) 
30 (53.6) 
18 (32.1) 
8 (14.3) 
17 (30.4) 
11 (19.6) 
28 (50.0) 
46 {82.1) 
27 (48.2) 
li {19.6) 
18 (32.1) 
14 {25.0) 
6 (10.7) 
4 (7.1) 
1 (1.8) 
1 (1.8) 
1 (1.8) 
11 (19.6) 
5 (8.9) 
12 {21.4) 
11 (19.6) 
8 (14.6) 
3 (5.4) 
4 (7.1) 
1 (1.8) 
1 {1.8) 
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Figure 3. Kaplan-Meier survival curves. 
Amputations were performed in 12 patients (21.4%) at a median 
time of 41 [range 17-167] days, corresponding to six minor and six 
major amputations. At the end of the follow-up, the limb salvage 
rate was 88.0% ( 44 from the 50 patients with critical limb 
ischaemia). 
Factors related to survival and patency 
We used the Log Rank test to assess the variables significantly 
related to patency rates. 
Neither clinical nor surgical variables were associated with 
primmy patency rates. 
Vein diameter was inversely related to primmy assisted rates. An 
increase of 1 mm reduced the risk of occlusion by about 50% 
(HR = 0.54, 95% confidence interval [0.30-0.98], p = 0.04). 
For secondmy patency rates, a significant association was found 
with spliced vein graft (p < 0.01) but it was not possible to assess 
HR as one group (single vesse!) had a 3-year patency rate of 100%, 
whereas the group which received a spliced graft had a patency rate 
of 73.1 ± 9.6% (see supplemental Fig. 1 ). 
By contrast, the location of a landing vesse! (above/below knee/ 
distal) did not statistically influence the outcome. 
Concerning the stage of ischaemia, the patency rates of Ruth-
erford stage 3 versus 4-6 were not statistically different. This Jack 
of difference is probably due to the small number of patients with 
stage 3. 
Discussion 
The results of our study suggest that arm veins contribute to 
satisfying results in terms ofpatency rates and limb salvage. lndeed, 
we performed IB with arm veins in 56 patients who were treated 
mostly for critical limb ischaemia with a limb salvage of 88% at 3 
years. 
Many studies have highlighted the superiority of venous 
conduits compared to synthetic ones for infrainguinal revascular-
isation.3·7·14 Peirera et al. published in 2006 a meta-analysis of 
femoropopliteal bypass grafts for lower extremity insufficiency and 
concluded that GSV performs better than PTFE in femoropopliteal 
bypass grafting and should be used whenever possible.25 
Mahmood et al. reported that even composite (vein-prosthetic) 
sequential grafts are notas good as the autologous vein. lnterest-
ingly, they found no difference in patency between composite 
grafts constructed from the arm or leg vein.26 Severa! retrospective 
studies have shown that even alternative veins ( other than GSV) 
have satisfactory patency rates.3.4·10•11 •15•18 Previously, the arm vein 
was usually used to perform ve1y distal bypass in patients without 
GSV or as an alternative to preserve the contralateral GSV. ln these 
cases, some studies have achieved secondary patency and limb 
salvage rates equal to those of GSV. 3.4·11·15•18 
We decided to use arm veins each time as they were the best 
conduits available even ifthe GSV was present. This idea is based on 
the fact that the long-tenu survival of grafts depends first and 
foremost on the quality of the conduit.6- 9 During the same study 
period and with the same policy, Arvela et al. have compared 130 
arm vein grafts with 160 prosthetic ones. Their results confirmed 
the superiority of arm veins over prosthetic conduits, even when 
spliced (patency is not statistically affected by the number of vein 
segments). 27 
Vein quality was assessed preoperatively by duplex mapping. 
We defined a vein to be of poor quality when one or more criteria 
were observed, such as diameter <2.5 mm, thrombosis, aneurysm, 
focal or diffuse wall thickening or calcifications and intraluminal 
webs. We selected arm vein when the diameter was sufficient, the 
quality was excellent and the length adequate for harvesting. US 
mapping is crucial due to the numerous vein punctures in hospi-
talised patients, which is harmful for patency. 
As in other studies, it is important to note that arm vein bypass 
results are not really comparable with GSV bypass because 
patients' basic vascular status is worse (high rate of recto 
operations). 
Nevertheless, our results of patency and limb salvage at 3 
years were quite satisfying and even similar to those using GSV, 
being comparable to those found in the literature.4·5·18·19 The 
endovascular treatment of critical limb ischaemia is increasing ail 
around the world. The Basil trial comparing endovascular and 
open surgery concluded that patients with life expectancy >2 
years and good quality of GSV should be treated by open 
surgery.28 Our study supports the fact that vein arms should be 
explored by US and used when available because they contribute 
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:a good results in terms of patency rates. The absence of GSV in 
ihe presence of good vein arms should be evoked when an 
indovascular treatment for long arterial occlusion is considered. 
ln this analysis, vein diameter was shown to be an important 
protective factor of assisted patency rates, whereas it exerted no 
itatistically significant effect on seconda1y patency rates. 
Vein diameter is probably not the only factor influencing the 
occlusion rate which could be more affected by conduit, inflow 
and outflow qualities. ln contrast to vein diameter, spliced vein 
1rafts significantly decreased the secondary patency rates. This is 
probably related to the number of anastomoses. To minimise the 
1tenosing effect of anastomosis, we made separate simple stitch 
1utures. We performed systematic duplex scanning of the 
bypasses to treat significative stenosis before occlusion. The strict 
follow-up of patients should be accurate during the first 6 
rnonths because 50% of the occlusion occurs during the first half-
year.5 
During the study period, the management of significative 
stenosis was surgical in a majority of cases (85%) because we 
previously had experiment arm vein rupture during balloon 
angioplasty. Actually, we carefully performe balloon angioplasty 
ourselves in the operating room and this is the procedure we prefer 
for treatment of stenosis. 
Regarding the relatively low survival rate, it should be noted 
that the average age of our patients was older than in most cited 
publications (where the average ages tend to be <70 y), and that 
their general health status was relatively bad (mean ASA score of 
3.02). According to Swiss statistical reports, more than 30% of 
patients had reached their life expectancy (mean male/female life 
expectancy in 2004 was 78.6/83.7 years) at the time of surgery.29 
Our study has some limitations. Even if ail !Bs are recorded 
prospectively in our department, the retrospective analysis has 
mme disadvantage linked to the design of the study. Moreover, the 
srnall number of patients did not permit us to generalise the results 
to every patient waiting for an IB. 
ln summary, we conclude that arm veins have good primary and 
secondary patency rates even after 3 years with very few harvest-
ing complications. 18·30 Arm veins selection by preoperative US 
mapping using defined criteria is essential to get the optimal 
conduit even if spliced graft is necessary at the end. lts performance 
should be evaluated by per-op flow measurement using a sterile 
ultrasound surgical probe, thereby allowing time to react in case 
of inadequate values. Thereafter, a systematic duplex surveillance 
programme is recommended to detect and treat the possible 
stenosis.3.4·15·18 When these procedures are followed, there is 110pe 
for limb salvage in the majority of cases. 
Therefore, arm veins quality should always be evaluated when 
good quality GSV is absent. Spliced vein grafts are effective when no 
long segment is available. 
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